SCHEMBL22707991

SCHEMBL22707991

c1ccc(-c2ccccc2-c2c3ccccc3c(-c3ccc(-c4cccc5ccccc45)c4oc5ccccc5c34)c3ccccc23)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDC14B O60729 2/20 0.41
▸ CDC14A Q9UNH5 2/20 0.41
▸ ALOX5 P09917 2/20 0.39
▸ ALDH1A1 P00352 4/20 0.38
▸ KDM4E B2RXH2 3/20 0.38
▸ MAPT P10636 3/20 0.38
▸ TDP1 Q9NUW8 2/20 0.38
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ HSD17B10 Q99714 2/20 0.38
▸ TP53 P04637 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ NFKB1 P19838 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ NFKB2 Q00653 1/20 0.38
▸ RELA Q04206 1/20 0.38
▸ ATM Q13315 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ GAA P10253 1/20 0.35
▸ MAOB P27338 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22707189 0.95 CDC14B (0.44) CDC14BCDC14AALOX5ALDH1A1KDM4E
SCHEMBL24897291 0.95 CDC14B (0.41) CDC14BCDC14AALOX5ALDH1A1KDM4E
SCHEMBL18382885 0.95 CDC14B (0.41) CDC14BCDC14AALOX5ALDH1A1KDM4E
SCHEMBL20334105 0.93 CDC14B (0.41) CDC14BCDC14AALOX5ALDH1A1KDM4E
SCHEMBL21131666 0.93 ALOX5 (0.40) CDC14BCDC14AALOX5ALDH1A1KDM4E
SCHEMBL22708079 0.93 ALOX5 (0.41) CDC14BCDC14AALOX5ALDH1A1KDM4E
SCHEMBL22854866 0.92 CDC14B (0.41) CDC14BCDC14AALOX5ALDH1A1KDM4E
SCHEMBL22952683 0.92 CDC14B (0.46) CDC14BCDC14AALOX5ALDH1A1KDM4E
SCHEMBL22707092 0.92 ALOX5 (0.42) CDC14BCDC14AALOX5ALDH1A1KDM4E
SCHEMBL22707992 0.90 ALDH1A1 (0.38) CDC14BCDC14AALOX5ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11780856-B2 Compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2023-10-10 — — US disclosed
US-11780856-B2 Compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2023-10-10 — — US disclosed
US-11685751-B2 Compound and organic light-emitting element comprising same LG CHEM, LTD. (KR) 2023-06-27 — — US disclosed
US-11685751-B2 Compound and organic light-emitting element comprising same LG CHEM, LTD. (KR) 2023-06-27 — — US disclosed
US-20230002420-A1 ORGANIC LIGHT-EMITTING ELEMENT LG CHEM, LTD. (KR) 2023-01-05 — — US disclosed
US-20220399501-A1 ORGANIC LIGHT-EMITTING ELEMENT LG CHEM, LTD. (KR) 2022-12-15 — — US disclosed
US-20220153758-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2022-05-19 — — US disclosed
US-20210391547-A1 BORON-CONTAINING COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2021-12-16 — — US disclosed
US-20200373496-A1 ORGANIC LIGHT EMITTING ELEMENT LG CHEM, LTD. (KR) 2020-11-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230002420-A1 ORGANIC LIGHT-EMITTING ELEMENT CYBA, CRY1, CYP1A1 CDC14B 4399/4885CDC14A 4379/4885ALOX5 1052/4885
US-20220399501-A1 ORGANIC LIGHT-EMITTING ELEMENT CYP1A1, AHR, CYP1B1 CDC14B 4677/4885CDC14A 4633/4885ALOX5 891/4885
US-20220153758-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CCNY, CDYL, NR1H2 CDC14B 3215/4885CDC14A 3592/4885ALOX5 1767/4885
US-11780856-B2 Compound and organic light-emitting device comprising same CRY1, CRY2, LEF1 CDC14B 3620/4885CDC14A 3390/4885ALOX5 887/4885
US-20210391547-A1 BORON-CONTAINING COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME CRY1, POU2F1, LEF1 CDC14B 3126/4885CDC14A 3360/4885ALOX5 2618/4885
US-11685751-B2 Compound and organic light-emitting element comprising same CRY1, CRY2, LEF1 CDC14B 3633/4885CDC14A 3451/4885ALOX5 1032/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback